Cargando…
Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997–2019
Background: Botulism is a low incidence but potentially fatal infectious disease caused by neurotoxins produced mainly by Clostridium botulinum. There are different routes of acquisition, food-borne and infant/intestinal being the most frequent presentation, and antitoxin is the treatment of choice...
Autores principales: | Peñuelas, Marina, Guerrero-Vadillo, María, Valdezate, Sylvia, Zamora, María Jesús, Leon-Gomez, Inmaculada, Flores-Cuéllar, Ángeles, Carrasco, Gema, Díaz-García, Oliva, Varela, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863742/ https://www.ncbi.nlm.nih.gov/pubmed/36668823 http://dx.doi.org/10.3390/toxins15010002 |
Ejemplares similares
-
Exploring the genetic background of the botulism neurotoxin BoNT/B2 in Spain
por: Valdezate, Sylvia, et al.
Publicado: (2023) -
Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model
por: Emanuel, Andrew, et al.
Publicado: (2019) -
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product
por: Anderson, Deborah M., et al.
Publicado: (2019) -
Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques
por: Kodihalli, Shantha, et al.
Publicado: (2017) -
Exposure‐Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product
por: Beliveau, Martin, et al.
Publicado: (2022)